Patents by Inventor Thomas Michael WAUGH

Thomas Michael WAUGH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260137680
    Abstract: The invention relates to compounds of formula (I): and their use in treating or preventing inflammatory diseases or diseases associated with an undesirable immune response, and to related compositions, methods and intermediate compounds.
    Type: Application
    Filed: June 22, 2023
    Publication date: May 21, 2026
    Inventors: Saleh AHMED, Michael Liam COOKE, Alessandro MAZZACANI, Thomas Michael WAUGH
  • Patent number: 12617762
    Abstract: The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: (I) wherein, RA1, RA2, RC and RD are as defined herein.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: May 5, 2026
    Assignee: Sitryx Therapeutics Limited
    Inventors: Michael Liam Cooke, David Cousin, Matthew Colin Thor Fyfe, Thomas Michael Waugh, Saleh Ahmed, Alessio De Simone, Barry John Teobald
  • Patent number: 12390437
    Abstract: The invention relates to compounds of formula (IW-1) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: wherein RA, RB, RC and RD are as defined herein.
    Type: Grant
    Filed: April 30, 2020
    Date of Patent: August 19, 2025
    Assignee: Sitryx Therapeutics Limited
    Inventors: Michael Liam Cooke, David Cousin, Matthew Colin Thor Fyfe, Barry John Teobald, Stephen Malcolm Thom, Thomas Michael Waugh
  • Publication number: 20230219907
    Abstract: The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: (I) wherein, RA1, RA2, RC and RD are as defined herein.
    Type: Application
    Filed: December 23, 2020
    Publication date: July 13, 2023
    Applicant: Sitryx Therapeutics Limited
    Inventors: Michael Liam COOKE, David COUSIN, Matthew Colin Thor FYFE, Thomas Michael WAUGH, Saleh AHMED, Alessio DE SIMONE, Barry John TEOBALD
  • Publication number: 20220265595
    Abstract: The invention relates to compounds of formula (IW-1) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: wherein RA, RB, RC and RD are as defined herein.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 25, 2022
    Inventors: Michael Liam COOKE, David COUSIN, Matthew Colin Thor FYFE, Barry John TEOBALD, Stephen Malcolm THOM, Thomas Michael WAUGH